Implementation and clinical benefit of DPYD genotyping in a Danish cancer population.

ESMO open(2023)

引用 1|浏览9
暂无评分
摘要
We found no population-level benefit of DPYD genotyping when comparing the risk of grade ≥3 FP-TOX before and after clinical implementation. We observed no deaths or FP-related hospitalizations in patients whose FP treatment was guided by a variant DPYD genotype. The use of DPD phenotyping may add valuable information in DPYD wild-type patients.
更多
查看译文
关键词
DPD deficiency,DPD phenotype,DPYD genotype
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要